Total Payments
$11,337
2024 Payments
$1,801
Companies
44
Transactions
551
Medicare Patients
1,927
Medicare Billing
$257,361
Payment Breakdown by Category
Food & Beverage$10,534 (92.9%)
Consulting$450.00 (4.0%)
Travel$234.40 (2.1%)
Education$117.93 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,534 | 545 | 92.9% |
| Consulting Fee | $450.00 | 3 | 4.0% |
| Travel and Lodging | $234.40 | 1 | 2.1% |
| Education | $117.93 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,594 | 145 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,185 | 63 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $995.66 | 56 | $0 (2024) |
| PFIZER INC. | $741.72 | 36 | $0 (2024) |
| Boston Scientific Corporation | $511.20 | 7 | $0 (2023) |
| Biogen, Inc. | $450.00 | 3 | $0 (2023) |
| Allergan Inc. | $443.74 | 45 | $0 (2018) |
| Gilead Sciences, Inc. | $403.41 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $382.68 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $336.08 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,801 | 69 | Janssen Biotech, Inc. ($310.96) |
| 2023 | $1,543 | 68 | AbbVie Inc. ($289.91) |
| 2022 | $1,699 | 73 | ABBVIE INC. ($391.71) |
| 2021 | $755.01 | 30 | AbbVie Inc. ($211.59) |
| 2020 | $215.27 | 13 | AbbVie Inc. ($57.99) |
| 2019 | $2,235 | 96 | AbbVie, Inc. ($567.92) |
| 2018 | $2,056 | 115 | AbbVie, Inc. ($598.15) |
| 2017 | $1,034 | 87 | AbbVie, Inc. ($202.94) |
All Payment Transactions
551 individual payment records from CMS Open Payments — Page 3 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/09/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $82.02 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 04/01/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/25/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Immunology | ||||||
| 03/13/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: IMMUNOLOGY | ||||||
| 03/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Gastroenterology | ||||||
| 02/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/27/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Immunology | ||||||
| 02/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Neuroscience | ||||||
| 01/31/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $48.71 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 01/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/23/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Gastroenterology | ||||||
| 12/18/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/15/2023 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Biosimilars | ||||||
| 12/13/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Immunology | ||||||
| 12/12/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $45.67 | General |
| Category: General - EndoChoice_ENDO | ||||||
| 12/05/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/04/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 317 | 317 | $408,396 | $43,716 |
| 2022 | 9 | 448 | 450 | $565,369 | $57,997 |
| 2021 | 12 | 478 | 478 | $588,252 | $67,125 |
| 2020 | 17 | 684 | 687 | $833,944 | $88,523 |
Total Patients
1,927
Total Services
1,932
Medicare Billing
$257,361
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 24 | 24 | $6,624 | $2,478 | 37.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 22 | 22 | $24,948 | $2,143 | 8.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 36 | 36 | $40,752 | $2,080 | 5.1% |
| 91010 | Measurement of esophageal swallowing movement | Facility | 2021 | 28 | 28 | $9,044 | $1,464 | 16.2% |
| 91038 | Monitoring of gastroesophageal reflux including analysis and interpretation, prolonged (greater than 1 hour, up to 24 hours) | Facility | 2021 | 13 | 13 | $10,634 | $582.66 | 5.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 119 | 119 | $196,350 | $23,851 | 12.1% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 87 | 87 | $114,405 | $12,625 | 11.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 47 | 47 | $56,239 | $8,538 | 15.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2020 | 12 | 12 | $32,016 | $7,865 | 24.6% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 63 | 63 | $89,019 | $6,264 | 7.0% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 76 | 77 | $73,381 | $5,395 | 7.4% |
| 43264 | Removal of stone from bile or pancreatic duct using an endoscope | Facility | 2020 | 26 | 26 | $32,080 | $4,777 | 14.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 54 | 55 | $62,260 | $3,565 | 5.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 18 | 18 | $22,050 | $3,376 | 15.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2020 | 31 | 31 | $35,154 | $3,375 | 9.6% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2020 | 19 | 19 | $22,971 | $3,079 | 13.4% |
| 91010 | Measurement of esophageal swallowing movement | Facility | 2020 | 42 | 42 | $13,566 | $2,253 | 16.6% |
| 91038 | Monitoring of gastroesophageal reflux including analysis and interpretation, prolonged (greater than 1 hour, up to 24 hours) | Facility | 2020 | 25 | 25 | $20,450 | $1,151 | 5.6% |
| 43249 | Balloon dilation of esophagus using an endoscope | Facility | 2020 | 11 | 11 | $20,922 | $790.76 | 3.8% |
| 43262 | Incision of pancreatic outlet muscle using an endoscope | Facility | 2020 | 17 | 17 | $22,408 | $736.74 | 3.3% |
| 74328 | Radiological supervision and interpretation of insertion of catheter into biliary duct using an endoscope | Facility | 2020 | 24 | 25 | $7,400 | $717.44 | 9.7% |
| 45381 | Injections of large bowel using an endoscope | Facility | 2020 | 13 | 13 | $13,273 | $162.69 | 1.2% |
About Dr. Ronald Schwarz, MD
Dr. Ronald Schwarz, MD is a Gastroenterology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508905043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Schwarz, MD has received a total of $11,337 in payments from pharmaceutical and medical device companies, with $1,801 received in 2024. These payments were reported across 551 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($10,534).
As a Medicare-enrolled provider, Schwarz has provided services to 1,927 Medicare beneficiaries, totaling 1,932 services with total Medicare billing of $257,361. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Raleigh, NC
- Active Since 02/05/2007
- Last Updated 01/29/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1508905043
Products in Payments
- XIFAXAN (Drug) $823.62
- ENTYVIO (Biological) $635.27
- ZEPOSIA (Drug) $525.29
- STELARA (Biological) $523.86
- TYSABRI (Biological) $450.00
- SKYRIZI (Biological) $441.08
- DUPIXENT (Biological) $397.19
- XELJANZ (Drug) $373.65
- LINZESS (Drug) $372.43
- Cimzia (Drug) $310.14
- Humira (Biological) $295.19
- Entyvio (Biological) $261.29
- GENERAL THERAPIES (Device) $234.40
- INFLECTRA (Biological) $220.14
- Creon (Drug) $218.50
- XIFAXANIBSD (Drug) $211.44
- HUMIRA (Biological) $199.81
- TRULANCE (Drug) $198.02
- ZENPEP (Drug) $197.45
- RINVOQ (Biological) $176.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Raleigh
Sanjay Jagannath, M.d, M.D
Gastroenterology — Payments: $68,773
Gastroenterology $68,773
Dr. Alyson Johnson, Md, MD
Gastroenterology — Payments: $51,083
Gastroenterology $51,083
Dr. Rig Patel, Md, MD
Gastroenterology — Payments: $45,372
Gastroenterology $45,372
Dr. Henry Vanpala, M.d, M.D
Gastroenterology — Payments: $43,522
Gastroenterology $43,522
Neeraj Sachdeva, Md, MD
Gastroenterology — Payments: $20,208
Gastroenterology $20,208
Murtaza Parekh, Md, MD
Gastroenterology — Payments: $13,298
Gastroenterology $13,298